Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth

Kenneth M Petersen1, Lisa R Bulkow, Brian J McMahon

  • 1Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA.

Insights

Hepatitis B vaccine protection wanes by 5 years in most infants. While many children retain immune memory, some require booster doses. Further research is needed to determine optimal hepatitis B booster timing.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • The long-term protective immunity conferred by infant hepatitis B vaccination remains undetermined.
  • Infant hepatitis B vaccination is a standard public health intervention.
  • Understanding vaccine durability is crucial for public health policy.

Purpose of the Study:

  • To assess the duration of antibody protection against hepatitis B virus in children vaccinated from birth.
  • To evaluate the immunologic memory and response to booster doses in children with waning immunity.
  • To inform recommendations regarding hepatitis B booster vaccination schedules.

Main Methods:

  • Longitudinal follow-up of 363 low-risk children vaccinated at birth with hepatitis B vaccine.
  • Measurement of antibody to hepatitis B surface antigen (anti-HBs) titers at various ages (4-13 years).
  • Administration of booster doses to participants with nonprotective anti-HBs titers (<10 mIU/mL).

Main Results:

  • Anti-HBs titers declined below protective levels by 5-7 years in most children receiving recombinant vaccine, and by 9-13 years for plasma-derived vaccine.
  • A significant proportion of children with nonprotective titers responded robustly to a booster dose (61-91%).
  • Children born to hepatitis B surface antigen (HBsAg)-positive mothers showed similar waning immunity but a high response rate to boosters.

Conclusions:

  • Antibody protection from infant hepatitis B vaccination diminishes significantly within 5-13 years.
  • Most children demonstrate immunologic memory, but a notable fraction requires booster doses.
  • Further long-term studies are essential to establish the necessity and optimal timing for hepatitis B booster vaccinations.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...